• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的发病机制:从基因到环境

Hepatocellular carcinoma pathogenesis: from genes to environment.

作者信息

Farazi Paraskevi A, DePinho Ronald A

机构信息

Department of Genetics, Division of Medical Sciences, Harvard University, Boston, Massachusetts 02115, USA.

出版信息

Nat Rev Cancer. 2006 Sep;6(9):674-87. doi: 10.1038/nrc1934.

DOI:10.1038/nrc1934
PMID:16929323
Abstract

Hepatocellular carcinoma is among the most lethal and prevalent cancers in the human population. Despite its significance, there is only an elemental understanding of the molecular, cellular and environmental mechanisms that drive disease pathogenesis, and there are only limited therapeutic options, many with negligible clinical benefit. This Review summarizes the current state of knowledge of this, the most common and dreaded liver neoplasm, and highlights the principal challenges and scientific opportunities that are relevant to controlling this accelerating global health crisis.

摘要

肝细胞癌是人类最致命且最常见的癌症之一。尽管其意义重大,但对于驱动疾病发病机制的分子、细胞和环境机制,人们仅有初步的了解,且治疗选择有限,其中许多的临床获益微乎其微。本综述总结了关于这种最常见且可怕的肝脏肿瘤的当前知识状态,并强调了与控制这一加速演变的全球健康危机相关的主要挑战和科学机遇。

相似文献

1
Hepatocellular carcinoma pathogenesis: from genes to environment.肝细胞癌的发病机制:从基因到环境
Nat Rev Cancer. 2006 Sep;6(9):674-87. doi: 10.1038/nrc1934.
2
Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.攻克乙型肝炎病毒相关性肝细胞癌——现在就是未来。
Cancer Metastasis Rev. 2013 Jun;32(1-2):229-68. doi: 10.1007/s10555-012-9412-6.
3
The genetic and environmental basis of hepatocellular carcinoma.肝细胞癌的遗传和环境基础。
Discov Med. 2006 Oct;6(35):182-6.
4
Molecular pathogenesis of hepatocellular carcinoma.肝细胞癌的分子发病机制
J Surg Res. 2006 Nov;136(1):125-35. doi: 10.1016/j.jss.2006.04.013. Epub 2006 Oct 3.
5
Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes.肝细胞癌的发病机制:细胞、分子和代谢的序贯性变化
Prog Liver Dis. 1996;14:161-97.
6
Comparative molecular pathogenesis of hepatocellular carcinomas.肝细胞癌的比较分子发病机制
Prog Clin Biol Res. 1992;376:173-85.
7
Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.核因子-κB与肝脏炎症-纤维化-癌症轴
Hepatology. 2007 Aug;46(2):590-7. doi: 10.1002/hep.21802.
8
Pathogenesis of hepatocellular carcinoma and molecular therapies.肝细胞癌的发病机制与分子疗法
Curr Opin Gastroenterol. 2009 May;25(3):186-94. doi: 10.1097/MOG.0b013e32832962a1.
9
Natural history of hepatocellular carcinoma and current treatment options.肝细胞癌的自然史及当前的治疗选择。
Semin Nucl Med. 2008 Mar;38(2):S13-8. doi: 10.1053/j.semnuclmed.2007.10.004.
10
Potential role of novel hepatocellular carcinoma-associated gene IDD01 in promoting tumorigenesis of HepG2 cell line.新型肝细胞癌相关基因IDD01在促进HepG2细胞系肿瘤发生中的潜在作用。
Chin Med J (Engl). 2006 Oct 20;119(20):1709-14.

引用本文的文献

1
Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma.黄曲霉毒素诱导的p53畸变与乙型肝炎病毒在肝细胞癌中的协同作用。
J Xenobiot. 2025 Jun 20;15(4):96. doi: 10.3390/jox15040096.
2
Surface Gene Mutations of Hepatitis B Virus and Related Pathogenic Mechanisms: A Narrative Review.乙型肝炎病毒表面基因突变及其相关致病机制:一篇叙述性综述
Viruses. 2025 Jul 12;17(7):974. doi: 10.3390/v17070974.
3
Oncogenic viruses rewire the epigenome in human cancer.致癌病毒在人类癌症中重塑表观基因组。
Front Cell Infect Microbiol. 2025 Jun 10;15:1617198. doi: 10.3389/fcimb.2025.1617198. eCollection 2025.
4
PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein.PRMT1通过调节MYC蛋白的精氨酸甲基化修饰促进肝细胞癌的免疫逃逸。
Epigenetics. 2025 Dec;20(1):2509044. doi: 10.1080/15592294.2025.2509044. Epub 2025 May 22.
5
Microfabricated Organ-Specific Models of Tumor Microenvironments.肿瘤微环境的微制造器官特异性模型
Annu Rev Biomed Eng. 2025 May;27(1):307-333. doi: 10.1146/annurev-bioeng-110222-103522.
6
miRNAs-Set of Plasmatic Extracellular Vesicles as Novel Biomarkers for Hepatocellular Carcinoma Diagnosis Across Tumor Stage and Etiologies.作为跨肿瘤分期和病因的肝细胞癌诊断新型生物标志物的血浆细胞外囊泡中的miRNA组
Int J Mol Sci. 2025 Mar 12;26(6):2563. doi: 10.3390/ijms26062563.
7
METTL3 knockout accelerates hepatocarcinogenesis via inhibiting endoplasmic reticulum stress response.METTL3基因敲除通过抑制内质网应激反应加速肝癌发生。
FEBS Open Bio. 2025 Jul;15(7):1144-1158. doi: 10.1002/2211-5463.70023. Epub 2025 Mar 18.
8
Mint3 as a Molecular Target Activated in the Early Stage of Hepatocarcinogenesis.Mint3作为在肝癌发生早期被激活的分子靶点。
Int J Mol Sci. 2025 Feb 8;26(4):1430. doi: 10.3390/ijms26041430.
9
Current State of Evidence for Use of MRI in LI-RADS.肝脏影像报告和数据系统(LI-RADS)中使用MRI的证据现状
J Magn Reson Imaging. 2025 Sep;62(3):640-653. doi: 10.1002/jmri.29748. Epub 2025 Feb 21.
10
Pan-serological antibodies and liver cancer risk: a nested case-control analysis.全血清学抗体与肝癌风险:一项巢式病例对照分析。
Sci Rep. 2025 Feb 14;15(1):5450. doi: 10.1038/s41598-025-89629-2.